Company news
Aditxt, Inc. news in 2020
Aditxt, Inc.'s news releases, calls and decks from 2020, newest first.
Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore™ for COVID-19 Immune Monitoring Service
December 13, 2020
Aditxt Appoints Anthony Voorhies as Head of Business Development for AditxtScore™
November 19, 2020
Aditxt Secures CLIA Certification for AditxtScore™ Laboratory Operations in Richmond, VA, and Plans to Launch AditxtScore™ for COVID-19 as a Lab Developed Test (LDT)
November 18, 2020
Aditxt Provides Business Update and Files Third Quarter 2020 10-Q
November 12, 2020
Aditxt Announces First AditxtEngage™ Event, Continuing Series of Investor Opportunities to Engage with Company
October 1, 2020
Aditx Therapeutics Announces Closing of Upsized $9.6 Million Follow-On Public Offering
September 9, 2020
Aditxt Signs Collaboration Agreement with Salveo Diagnostics to Commercialize AditxtScore™ Platform Starting in Q4, 2020
September 2, 2020
Aditx Therapeutics Announces Pricing of $9.6 Million Follow-On Public Offering
September 1, 2020
Aditxt Submits Emergency Use Authorization (EUA) Application for AditxtScore™ for COVID-19
August 23, 2020
Aditxt Introduces AditxtScore™ for COVID-19 and Announces the Completion of Validation Studies by Stanford Blood Center
August 5, 2020
Aditx Therapeutics Appoints Jeff Ramson, Wall Street Veteran and Founder of PCG Advisory as Senior Advisor, Capital Markets & Communications
August 2, 2020
Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering
July 1, 2020